KYMERA THERAPEUTICS, INC.: cash_and_equivalents

Value{"amount": 156819000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Period (as of 2021-09-30)
Statuscurrent
EntityKYMERA THERAPEUTICS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000950170-21-003911 · Open the official SEC filing →
Retrieved: 2026-08-19T18:15:30.342910+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001815442/cash-and-equivalents/2021-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/56577ccd-73e1-438f-bdac-ae5dc64253ed

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies